Tetraphase Pharmaceuticals, Inc. approved the election of Dr. L. Patrick Gage and Ms. Nancy Wysenski as class I directors, each to serve for a three year term expiring at the 2017 annual meeting of stockholders at its annual meeting of stockholders held on June 12, 2014.
1st Jan change | Capi. | |
---|---|---|
+37.78% | 723B | |
+30.47% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.47% | 244B | |
-4.58% | 208B | |
+10.07% | 210B | |
+9.32% | 169B |